Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-19

Clinical Trial Update: Adjunctive Methylene Blue in Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjunctive methylene blue for septic shock has completed with status listed as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Dr. Shannon M. Fernando | Conditions: Septic Shock | Phase 3 | Status: COMPLETED